Stay updated with breaking news from Atxs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Astria Therapeutics, Inc. (NASDAQ:ATXS – Get Free Report)’s stock price dropped 2.9% during trading on Tuesday after HC Wainwright lowered their price target on the stock from $18.00 to $16.00. HC Wainwright currently has a buy rating on the stock. Astria Therapeutics traded as low as $9.51 and last traded at $9.52. Approximately 312,375 shares […] ....
Shares of Astria Therapeutics, Inc. (NASDAQ:ATXS – Get Free Report) reached a new 52-week high on Monday . The stock traded as high as $16.90 and last traded at $14.89, with a volume of 1263985 shares trading hands. The stock had previously closed at $15.13. Wall Street Analyst Weigh In ATXS has been the subject […] ....
Astria Therapeutics, Inc. (NASDAQ:ATXS – Get Free Report) reached a new 52-week high during mid-day trading on Monday . The stock traded as high as $16.90 and last traded at $14.89, with a volume of 1263985 shares traded. The stock had previously closed at $15.13. Wall Street Analysts Forecast Growth A number of research firms […] ....
Astria Therapeutics (NASDAQ:ATXS – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at HC Wainwright in a note issued to investors on Monday, Benzinga reports. They currently have a $18.00 target price on the biotechnology company’s stock. HC Wainwright’s price objective would suggest a potential upside of 20.16% from the company’s […] ....